Gujarat Themis Biosyn Limited

Company Profile

Gujarat Themis Biosyn Limited had its IPO on under the ticker symbol 506879.

The company operates in the Other sector and Other industry. Gujarat Themis Biosyn Limited has a staff strength of 101 employees.

Stock update

Shares of Gujarat Themis Biosyn Limited opened at ₹806 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹770.6 - ₹809.45, and closed at ₹791.4.

This is a -1.28% slip from the previous day's closing price.

A total volume of 15,072 shares were traded at the close of the day’s session.

In the last one week, shares of Gujarat Themis Biosyn Limited have slipped by -1.88%.

Gujarat Themis Biosyn Limited's Key Ratios

Gujarat Themis Biosyn Limited has a market cap of ₹3.69 billion, indicating a price to book ratio of 7.4555 and a price to sales ratio of 4.2403.

In the last 12-months Gujarat Themis Biosyn Limited’s revenue was ₹890.80 million with a gross profit of ₹725.05 million and an EBITDA of ₹385.92 million. The EBITDA ratio measures Gujarat Themis Biosyn Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Gujarat Themis Biosyn Limited’s operating margin was 41.75% while its return on assets stood at 0% with a return of equity of 0%.

In Q2, Gujarat Themis Biosyn Limited’s quarterly earnings growth was a positive 295.9% while revenue growth was a positive 33.8%.

Gujarat Themis Biosyn Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

11.2505

PEG

Its diluted EPS in the last 12-months stands at ₹19.181 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Gujarat Themis Biosyn Limited’s profitability.

Gujarat Themis Biosyn Limited stock is trading at a EV to sales ratio of 4.518 and a EV to EBITDA ratio of 10.4487. Its price to sales ratio in the trailing 12-months stood at 4.2403.

Gujarat Themis Biosyn Limited stock pays annual dividends of ₹1.65 per share, indicating a yield of 0.6% and a payout ratio of 9.14%.

Balance sheet and cash flow metrics

Total Assets

₹1.66 billion

Total Liabilities

₹152.78 million

Operating Cash Flow

₹-204076000.00

Capital Expenditure

₹237.02 million

Dividend Payout Ratio

9.14%

Gujarat Themis Biosyn Limited ended 2024 with ₹1.66 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.66 billion while shareholder equity stood at ₹1.49 billion.

Gujarat Themis Biosyn Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹152.78 million in other current liabilities, 72644000.00 in common stock, ₹1.42 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹60.55 million and cash and short-term investments were ₹102.31 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.

Gujarat Themis Biosyn Limited’s total current assets stands at ₹608.47 million while long-term investments were ₹0 and short-term investments were ₹8.97 million. Its net receivables were ₹179.05 million compared to accounts payable of ₹0 and inventory worth ₹146.19 million.

In 2024, Gujarat Themis Biosyn Limited's operating cash flow was ₹-204076000.00 while its capital expenditure stood at ₹237.02 million.

Comparatively, Gujarat Themis Biosyn Limited paid ₹0.09 in dividends in 2024.

Other key metrics

Current Trading Price

₹791.4

52-Week High

₹921.05

52-Week Low

₹492.3401

Analyst Target Price

₹

Gujarat Themis Biosyn Limited stock is currently trading at ₹791.4 per share. It touched a 52-week high of ₹921.05 and a 52-week low of ₹921.05. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹795.94 and 200-day moving average was ₹752.19 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 7650% of the company’s stock are held by insiders while 0% are held by institutions.